Clinical Trial Update: Lorazepam Sedation for Critically Ill Children [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on lorazepam sedation in critically ill children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

Sponsor: The Emmes Company, LLC | Conditions: Critical Illness | Phase 2, Phase 3 | Status: COMPLETED